ghk-cu activation serum PDRN / Cu face and neck

BPC-157 500 mcg · 60 Capsules — Batch Tested | AdAstra Labs

At the time, her diagnosis was unknown

cell metabolism

Size:150 ct. (30 servings)

doi:10.1007/s00702-012-0893-9 · PubMed 23008029 Frequently Asked Questions In the two placebo-controlled PREEMPT trials (687 patients on Botox, 692 on placebo), the adverse reactions the FDA label lists as more frequent with Botox were neck pain (9% versus 3%), headache (5% versus 3%), migraine (4% versus 3%), eyelid droop or ptosis (4% versus under 1%), musculoskeletal stiffness (4% versus 1%), muscle weakness (4% versus under 1%), and myalgia, musculoskeletal pain, injection-site pain, bronchitis, facial weakness, and muscle spasms each at 2–3%

Cu face and neck serum has 1200mg of Copper Tripeptide